It's no secret that the healthcare market can be tough, and we know exactly what you are up against. At inVentiv Health, we offer the passion, expertise and strategic insights necessary to navigate the challenges of this complex, global terrain. When you partner with us, we do what it takes to get your product successfully from lab to life.
As a global, top-tier, clinical and commercial professional services company, we work with you to evolve and innovate. We've already challenged the status quo by combining a global Clinical Research Organization (CRO) with a global Contract Commercial Organization (CCO) to create a smoother, better process. By combining the best strategic brains in the biopharmaceutical industry with the latest technologies, we've worked to eliminate the roadblocks, territories, fences, hand-offs and gaps that can hinder the efficiency and speed at which you bring products into the hands of those who need them most.
inVentiv Health offers best practices, processes and systems to enable biopharmaceutical clients to successfully navigate an increasingly complex operating environment. We have more than 15,000 healthcare professionals servicing clients in 90 countries. The company has helped to develop or commercialize 80 percent of all new drugs approved by the FDA and 70 percent approved by the EMA over the last five years. So, we have the proven model to help drive your product successfully from lab to life.
Our therapeutic expertise is
“To realize the potential of our technology and move quickly into market, we sought a partner that could execute every phase and function in commercialization – and inVentiv was the obvious choice.”– Chief Executive Officer, Aprecia
"I was very impressed with the level of industry knowledge...it was a pleasure to work with the team."– Client at Pfizer
"I felt inVentiv was a company that could read between the lines and see the bigger picture of what we’re trying to achieve – from a long-term point of view."– Vice President Sales, Top 10 Pharma
"inVentiv will become even more important to us in the future as we face margin compression, patent cliffs, and the changes in healthcare."– Vice President Sales, Top 10 Pharma
"After an extensive global review of potential clinical research organizations, we selected the broad-scale inVentiv platform as an important differentiator for our program."– President and CEO, Advaxis